LASSBio-2060

N/A

Report date: 2025/03/20 15:40:43

NME

Base Information

Drug NameLASSBio-2060

Drug Alias Nameanti-inflammatory agents (Federal University of Rio de Janeiro)LASSBio-1829Cl analogs (Federal University of Rio de Janeiro)LASSBio-2061

ClassificationSmall molecules > Heterocyclic drugs

Mechanisms of ActionUpdating

TargetsUpdating

Therapy Area/IndicationsInflammation

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryBrazil

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesUniversidade Federal Do Rio De Janeiro

China Registration ClassN/A

Develop Information

Active CompaniesUniversidade Federal Do Rio De Janeiro

Inactive CompaniesN/A

Active IndicationsInflammation

Inactive IndicationsN/A

Other Information

ATC CodeN/A